• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five Forces Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Material
o Market segments
o Comparison by Material
o Biologic vascular patches – Market size and forecast 2019-2024
o Synthetic vascular patches – Market size and forecast 2019-2024
o Market opportunity by Material
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o Asia – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Volume drivers – Demand led growth
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o Baxter International Inc.
o B. Braun Melsungen AG
o CryoLife Inc.
o Getinge Group
o Labcor Laboratorios LTDA
o RTI Surgical Holdings Inc.
o Terumo Corp.
• W. L. Gore & Associates Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2019 – 2024 ($ million)
• 13: Global market: Year-over-year growth 2019 – 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2019
• 21: Material – Market share 2019-2024 (%)
• 22: Comparison by Material
• 23: Biologic vascular patches – Market size and forecast 2019-2024 ($ million)
• 24: Biologic vascular patches – Year-over-year growth 2019-2024 (%)
• 25: Synthetic vascular patches – Market size and forecast 2019-2024 ($ million)
• 26: Synthetic vascular patches – Year-over-year growth 2019-2024 (%)
• 27: Market opportunity by Material
• 28: Customer landscape
• 29: Market share by geography 2019-2024 (%)
• 30: Geographic comparison
• 31: North America – Market size and forecast 2019-2024 ($ million)
• 32: North America – Year-over-year growth 2019-2024 (%)
• 33: Europe – Market size and forecast 2019-2024 ($ million)
• 34: Europe – Year-over-year growth 2019-2024 (%)
• 35: Asia – Market size and forecast 2019-2024 ($ million)
• 36: Asia – Year-over-year growth 2019-2024 (%)
• 37: ROW – Market size and forecast 2019-2024 ($ million)
• 38: ROW – Year-over-year growth 2019-2024 (%)
• 39: Key leading countries
• 40: Market opportunity by geography ($ million)
• 41: Impact of drivers and challenges
• 42: Vendor landscape
• 43: Landscape disruption
• 44: Industry risks
• 45: Vendors covered
• 46: Market positioning of vendors
• 47: Abbott Laboratories – Overview
• 48: Abbott Laboratories – Business segments
• 49: Abbott Laboratories – Key offerings
• 50: Abbott Laboratories – Key customers
• 51: Abbott Laboratories – Segment focus
• 52: Baxter International Inc. – Overview
• 53: Baxter International Inc. – Business segments
• 54: Baxter International Inc. – Key offerings
• 55: Baxter International Inc. – Key customers
• 56: Baxter International Inc. – Segment focus
• 57: B. Braun Melsungen AG – Overview
• 58: B. Braun Melsungen AG – Business segments
• 59: B. Braun Melsungen AG – Key offerings
• 60: B. Braun Melsungen AG – Key customers
• 61: B. Braun Melsungen AG – Segment focus
• 62: Becton, Dickinson and Co. – Overview
• 63: Becton, Dickinson and Co. – Business segments
• 64: Becton, Dickinson and Co. – Key offerings
• 65: Becton, Dickinson and Co. – Key customers
• 66: Becton, Dickinson and Co. – Segment focus
• 67: CryoLife Inc. – Overview
• 68: CryoLife Inc. – Business segments
• 69: CryoLife Inc. – Key offerings
• 70: CryoLife Inc. – Key customers
• 71: CryoLife Inc. – Segment focus
• 72: Getinge Group – Overview
• 73: Getinge Group – Business segments
• 74: Getinge Group – Key offerings
• 75: Getinge Group – Key customers
• 76: Getinge Group – Segment focus
• 77: Labcor Laboratorios LTDA – Overview
• 78: Labcor Laboratorios LTDA – Product and service
• 79: Labcor Laboratorios LTDA – Key offerings
• 80: Labcor Laboratorios LTDA – Key customers
• 81: Labcor Laboratorios LTDA – Segment focus
• 82: RTI Surgical Holdings Inc. – Overview
• 83: RTI Surgical Holdings Inc. – Business segments
• 84: RTI Surgical Holdings Inc. – Key offerings
• 85: RTI Surgical Holdings Inc. – Key customers
• 86: RTI Surgical Holdings Inc. – Segment focus
• 87: Terumo Corp. – Overview
• 88: Terumo Corp. – Business segments
• 89: Terumo Corp. – Key offerings
• 90: Terumo Corp. – Key customers
• 91: Terumo Corp. – Segment focus
• 92: W. L. Gore & Associates Inc. – Overview
• 93: W. L. Gore & Associates Inc. – Product and service
• 94: W. L. Gore & Associates Inc. – Key offerings
• 95: W. L. Gore & Associates Inc. – Key customers
• 96: W. L. Gore & Associates Inc. – Segment focus
• 97: Currency conversion rates for US$
• 98: Research Methodology
• 99: Validation techniques employed for market sizing
• 100: Information sources
• 101: List of abbreviations
【掲載企業】
Abbott Laboratories, Baxter International Inc., B. Braun Melsungen AG, Becton, Dickinson and Co., CryoLife Inc., Getinge Group, Labcor Laboratorios LTDA, RTI Surgical Holdings Inc., Terumo Corp., W. L. Gore & Associates Inc.
【免責事項】
https://www.marketreport.jp/reports-disclaimer